Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group-Reference-Cited by-同舟云学术

Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group

Published:2010-01 Issue:1 Volume:46 Page:84-94
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Eiermann Wolfgang,Graf Erika,Ataseven Beyhan,Conrad Bettina,Hilfrich Jörn,Massinger-Biebl Heidi,Vescia Sabine,Loibl Sibylle,von Minckwitz Gunter,Schumacher Martin,Kaufmann Manfred

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes;Buzzoni;J Clin Oncol,1991

2. CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93);Von Minckwitz;Eur J Cancer,2006

3. A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer – GABG-IV B-93;Kaufmann;Eur J Cancer,2007

4. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93) – the German Adjuvant Breast Cancer Group;Kaufmann;J Clin Oncol,2005

5. A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil and either doxorubicin or epirubicin;J Clin Oncol,1988

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review;Journal of Experimental & Clinical Cancer Research;2013-11-11

2. Epirubicin: Is it like doxorubicin in breast cancer? A clinical review;The Breast;2012-04

3. Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?;Medical Oncology;2010-04-14